Cannara Biotech (DE:8CB0)
FRANKFURT:8CB0
Holding DE:8CB0?
Track your performance easily

Cannara Biotech (8CB0) Cash flow

0 Followers

Cannara Biotech Cash Flow

DE:8CB0's free cash flow for Q3 2024 was C$6.35M. For the 2024 fiscal year, DE:8CB0's free cash flow was decreased by C$17.23M and operating cash flow was C$4.33M. See a summary of the company’s cash flow.
Cash Flow
TTM
Aug 23Aug 22Aug 21Aug 20Aug 19
Operating Cash Flow
C$ 9.86MC$ 5.44MC$ -6.08MC$ -2.09MC$ -9.32MC$ -7.41M
Investing Cash Flow
C$ -6.38MC$ -9.48MC$ -15.35MC$ -30.83MC$ -8.55MC$ -21.64M
Financing Cash Flow
C$ -2.04MC$ -3.72MC$ 25.46MC$ 33.25MC$ -914.82KC$ 42.66M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ 34.49MC$ 4.27MC$ 16.86MC$ 8.16MC$ 7.77MC$ 26.51M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
---C$ 24.30M-C$ 46.23M
Issuance Of Debt
C$ 6.46MC$ 699.26KC$ 26.63MC$ 10.08MC$ 6.00MC$ 0.00
Repayment Of Debt
C$ -2.24MC$ -2.30MC$ -35.25MC$ -616.34KC$ -6.56MC$ -235.45K
Free Cash Flow
C$ 6.33MC$ -4.25MC$ -21.48MC$ -2.09MC$ -18.64MC$ -29.73M
Domestic Sales
------
Foreign Sales
------
Currency in CAD

Cannara Biotech Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis